Original Source(s)
Related Content
FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI
The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.
June 15, 2026
-
3 min
Diet-Dementia Link Varies by Biomarkers
Effects varied by which biomarker and diet were measured, and the study stops short of proving diet changes risk.
June 29, 2026
-
7 min
Retinal Imaging AI May Flag Brain Health Risk
Authors said AI-driven retinal screening still lacks evidence that it improves patient outcomes.
by Kerri Miller
May 29, 2026
-
3 min
